Prognostic significance of tumour budding in noncolorectal gastrointestinal tract and pancreatobiliary tract: a systematic review and meta-analysis
- Ji Hyun Park 1, Jae Il Shin 2, Beom Jin Lim 3
- Ji Hyun Park 1, Jae Il Shin 2, Beom Jin Lim 3
- 1Yonsei University College of Medicine, Seoul, Republic of Korea.
- 2Department of Pediatrics, Yonsei University College of Medicine, Seoul, Republic of Korea.
- 3Department of Pathology, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul, Republic of Korea.
- 0Yonsei University College of Medicine, Seoul, Republic of Korea.
Related Experiment Videos
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Tumour budding, a promising cancer prognostic factor, indicates worse survival in esophageal, gastric, pancreatic, and biliary tract cancers. Standardized criteria are needed for its clinical use.
Area Of Science
- Oncology
- Pathology
- Biostatistics
Background
- Tumour budding is a potential prognostic marker in cancer.
- Its clinical application is limited by a lack of large, validated studies and standardized criteria.
- This meta-analysis focuses on noncolorectal gastrointestinal and pancreatobiliary tract cancers.
Approach
- A comprehensive literature review was performed using PubMed, Embase, and Web of Science up to February 20, 2023.
- Pooled odds ratios and hazard ratios were calculated to assess the association between tumour budding and clinicopathological features, as well as overall survival.
- Study quality was evaluated using the Newcastle-Ottawa Scale, and heterogeneity and publication bias were analyzed.
Key Points
- High-grade tumour budding was associated with significantly worse overall survival in esophageal squamous cell carcinoma, gastric adenocarcinoma, pancreatic ductal adenocarcinoma, and biliary tract adenocarcinoma.
- Tumour budding consistently correlated with adverse clinicopathological features, including lymph node metastasis, lymphovascular invasion, and distant metastasis.
- High heterogeneity was observed across the included studies.
Conclusions
- Tumour budding is a valuable prognostic marker in various gastrointestinal and pancreatobiliary tract cancers.
- Standardized criteria specific to organ types are essential to improve the clinical utility of tumour budding assessment.
- Further research with standardized methodologies is warranted to solidify its role in cancer prognosis.
Related Experiment Videos
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.

